Functional and Therapeutic Relevance of CD56(NCAM) Expression in Multiple Myeloma

被引：0
|
作者：
Gattenlohner, S.
Mottok, A.
Stuhmer, T.
Bargou, R.
Einsele, H.
Muller-Hermelink, H-K
机构：
[1] Med Univ Graz, Inst Pathol, Graz, Austria
[2] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1263
引用
收藏
页码：297A / 297A
页数：1
相关论文
共 50 条
  • [21] NCAM (CD56) Expression in keratin-producing odontogenic cysts: aberrant expression in KCOT
    Vera-Sirera, Beatriz
    Forner-Navarro, Leopoldo
    Vera-Sempere, Francisco
    HEAD & FACE MEDICINE, 2015, 11
  • [22] NCAM (CD56) Expression in keratin-producing odontogenic cysts: aberrant expression in KCOT
    Beatriz Vera-Sirera
    Leopoldo Forner-Navarro
    Francisco Vera-Sempere
    Head & Face Medicine, 11
  • [23] NCAM(CD56) AND CD31 IN PATIENTS WITH PRIMARY HYPERTENSION
    Soya, O. V.
    Kuryata, O. V.
    Nedzvedskiy, V. S.
    JOURNAL OF HYPERTENSION, 2009, 27 : S149 - S150
  • [24] Retrospective Analysis of the Expression of CD56 in Multiple Myeloma with Bone-Related Extramedullary Diseases
    Chen, Qingjiao
    Zheng, Xiaoqiang
    Lin, Qiaoxian
    Chen, Junmin
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2023, 53 (01): : 14 - 20
  • [25] CD56 expression is the potent prognostic marker of the thalidomide efficacy in the patients with multiple myeloma.
    Mori, A
    Tsutsumi, Y
    Hashino, S
    Kanamori, H
    Ibata, M
    Mashiko, S
    Masauzi, N
    Asaka, M
    Imamura, M
    BLOOD, 2005, 106 (11) : 368B - 369B
  • [26] Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma
    Dahl, IMS
    Rasmussen, T
    Kauric, G
    Husebekk, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 273 - 277
  • [27] Primary central nervous system (CNS) lymphomas lack expression of CD56 (NCAM)
    Huang, JC
    Karcher, DS
    Thomas, C
    Alkan, S
    LABORATORY INVESTIGATION, 1999, 79 (01) : 139A - 139A
  • [28] CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma
    Benjamin, Reuben
    Condomines, Maud
    Gunset, Gertrude
    Sadelain, Michel
    CANCER RESEARCH, 2012, 72
  • [29] Evaluation of CD133 and CD56/NCAM expression in Wilms tumor and their association with prognostic factors
    Jafarian, Amir Hossein
    Zabolinejad, Nona
    Roshan, Nema Mohamadian
    Hashemi, Sara
    Gharib, Masoumeh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (07) : 853 - 857
  • [30] NCAM (CD56)-POSITIVE MALIGNANT-LYMPHOMA - RESPONSE
    KERN, WF
    SPIER, CM
    GROGAN, TM
    BLOOD, 1992, 80 (09) : 2431 - 2432
12345